Ballwin, MO, United States of America

Jun Yang

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Jun Yang

Introduction

Jun Yang is an accomplished inventor based in Ballwin, Missouri. He holds a total of six patents, showcasing his significant contributions to the field of medical science. His work primarily focuses on developing innovative compounds for treating various medical conditions.

Latest Patents

Among his latest patents are the kappa opioid receptor peptide amide ligands. This invention provides kappa opioid receptor peptide agonists, methods for preparing these compounds, and compositions that include these agonists. These innovations are aimed at treating pain and other related conditions. Another notable patent involves peptides for the treatment of medical disorders. This invention offers selective kappa-opioid receptor agonists, methods for their preparation, and compositions that comprise these compounds, which are essential for treating kappa-opioid receptor-related medical disorders.

Career Highlights

Throughout his career, Jun Yang has worked with prominent companies such as Mallinckrodt, Inc. and Humanwell Pharmaceutical US. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Jun Yang has collaborated with notable professionals in his field, including Stephen H. Wu and Cliff J. Herman. These partnerships have further enhanced his research and development efforts.

Conclusion

Jun Yang's innovative work in the field of medical science, particularly in developing kappa opioid receptor agonists, has made a substantial impact. His contributions continue to pave the way for advancements in treating various medical disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…